Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fredy Geiger has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Progressive Bilateral Localised Amyloidosis of the Eyelids and Conjunctiva Four Years after MALT Lymphoma: A Case Report

    by Fredy Geiger, Alexandra Steinemann-Inauen, Peter Meyer

    Amyloidosis refers to a heterogeneous group of disorders characterized by the deposition of insoluble protein fibrils in various tissues, including the eyes and their adnexa. It can occur either systemically or locally and is classified based on the type of amyloid protein involved. To date, 42 different amyloid fibril proteins have been identified; however, not all are associated with ocular deposition [1]. Orbital and adnexal amyloidosis is rare and most commonly affects the eyelid, orbit, and conjunctiva. While it can be the initial manifestation of systemic involvement, most cases are localized with amyloid light-chain (AL) deposits being the most common, resulting from the accumulation of misfolded immunoglobulin light chains [2], [3]. Due to the heterogeneity of the disease and the limited literature available, the diagnosis and management of orbital and adnexal amyloidosis remain challenging. Received: 06 October 2025 Accepted: 02 December 2025 Article published online: 04 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 14, 70469 Stuttgart, Germany

  • Open Access

    Assessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging—A Retrospective Chart Review

    by Fredy Geiger, Sadiq Said, Anahita Bajka, Mario Damiano Toro, Maximilian Robert Justus Wiest, Marc Stahel, Daniel Barthelmes, Sandrine Anne Zweifel

    Using multimodal imaging, the literature proposed the following risk factors for choroidal nevus growth into melanoma: increased tumor thickness, subretinal fluid, decreased visual acuity, presence of orange pigment, ultrasound acoustic hollowness, and increased tumor diameter. This study investigated the presence of the mentioned risk factors in choroidal nevi, choroidal melanomas, and indeterminate choroidal melanocytic lesions. This retrospective, single-center chart review assessed choroidal melanocytic tumors with multimodal imaging. We defined our primary outcome as the cumulative presence of mentioned risk factors. Further, we evaluated various optical coherence tomography (OCT), ultrasound, and autofluorescence findings. We analyzed 51 tumors from 49 patients during the period from April 2008 to June 2021. The median (IQR) age was 64.0 (56.0 to 70.5) years, with 23 of 49 (46.9%) patients being female. The follow-up time for all tumors was median (IQR) 25.0 (12.0 to 39.0) months. The choroidal nevi had a median (range) risk score of 0.0 (0.0 to 3.0), and the choroidal melanoma of 5.0 (3.0 to 6.0), with statistically significant different ratings (p < 0.001). Multimodal imaging creates a score that may help to distinguish choroidal nevi from choroidal melanomas objectively.